Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ·Healthcare·Biotechnology
$11.91
-5.48%
Mkt Cap $1.07B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (6 analysts)
$35.00
Range $35.00 – $35.00
Implied Upside
+193.9%
Consensus $35.00 vs current $11.91
NASDAQ·Healthcare·Biotechnology
$11.91
-5.48%
Mkt Cap $1.07B
Buy
8
Hold
0
Sell
0
Price Target (6 analysts)
$35.00
Range $35.00 – $35.00
+193.9%
Consensus $35.00 vs current $11.91